Neurocrine Biosciences (NBIX) Earnings Per Share (EPS)
Market Cap: $10.53B
Avg Volume: 1.57M
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Earnings Per Share (EPS) Summary (Annual)
According to Neurocrine Biosciences's latest annual financial reports, the company has an earnings per share (EPS) of $3.4 and a diluted EPS of $3.29. The EPS indicates the portion of a company's profit allocated to each outstanding share of common stock, serving as an indicator of a company's profitability.
The company's EPS growth rate stands at 32.81%, and the diluted EPS growth rate is 33.20%. These metrics reflect the annual growth rate of earnings per share and diluted earnings per share over the specified period.
EPS
$3.4
Diluted EPS
$3.29
EPS Growth
32.81%
Neurocrine Biosciences Historical EPS
Neurocrine Biosciences Historical EPS Growth
EPS History
The table below shows the EPS for each year, with the latest data available for the last fiscal year 2024.
| Year | EPS | Change |
|---|---|---|
| 2024 | $3.4 | 32.81% |
| 2023 | $2.56 | 59.01% |
| 2022 | $1.61 | 69.47% |
| 2021 | $0.95 | -78.26% |
| 2020 | $4.37 | 992.50% |
| 2019 | $0.4 | 81.82% |
| 2018 | $0.22 | 113.58% |
| 2017 | $-1.62 | 0.61% |
| 2016 | $-1.63 | -55.24% |
| 2015 | $-1.05 | -29.63% |
| 2014 | $-0.81 | -17.39% |
| 2013 | $-0.69 | -1000.78% |
| 2012 | $0.0766 | -88.74% |
| 2011 | $0.68 | 553.33% |
| 2010 | $-0.15 | 88.46% |
| 2009 | $-1.3 | 43.48% |
| 2008 | $-2.3 | 57.80% |
| 2007 | $-5.45 | -91.90% |
| 2006 | $-2.84 | -373.33% |
| 2005 | $-0.6 | 52.38% |
| 2004 | $-1.26 | -35.48% |
| 2003 | $-0.93 | 70.00% |
| 2002 | $-3.1 | -118.31% |
| 2001 | $-1.42 | -9.23% |
| 2000 | $-1.3 | -47.73% |
| 1999 | $-0.88 | 20.00% |
| 1998 | $-1.1 | -466.67% |
| 1997 | $0.3 | -23.08% |
| 1996 | $0.39 | 0.00% |
Related Metrics
Explore detailed financial metrics and analysis for NBIX.